NextCure, Inc. (NASDAQ:NXTC – Get Free Report) major shareholder Adar1 Capital Management, Llc bought 3,410 shares of the company’s stock in a transaction on Wednesday, July 29th. Following the completion of the acquisition, the insider directly owned 393,266 shares of the company’s stock, valued at approximately $1,966,330. Adar1 Capital Management, Llc also recently made the following trade(s):Get NextCure alerts:On Tuesday, July 28th, Adar1 Capital Management, Llc purchased 6,400 shares of NextCure stock. On Monday, July 27th, Adar1 Capital Management, Llc purchased 7,798 shares of NextCure stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $19.00.